Model
Edge
Seres Therapeutics
0001808592
Filing Type
4
Filing Date
8/18/2024
Updated
8/19/24, 3:45 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership